Suppr超能文献

胃肠胰神经内分泌肿瘤的影像学检查

Imaging of gastroenteropancreatic neuroendocrine tumors.

作者信息

Tan Eik Hock, Tan Cher Heng

机构信息

Eik Hock Tan, Department of Nuclear Medicine and PET, Singapore General Hospital, Outram Road, Singapore 169608, Singapore.

出版信息

World J Clin Oncol. 2011 Jan 10;2(1):28-43. doi: 10.5306/wjco.v2.i1.28.

Abstract

Imaging of gastroenteropancreatic neuroendocrine tumors can be broadly divided into anatomic and functional techniques. Anatomic imaging determines the local extent of the primary lesion, providing crucial information required for surgical planning. Functional imaging, not only determines the extent of metastatic disease spread, but also provides important information with regard to the biologic behavior of the tumor, allowing clinicians to decide on the most appropriate forms of treatment. We review the current literature on this subject, with emphasis on the strengths of each imaging modality.

摘要

胃肠胰神经内分泌肿瘤的成像可大致分为解剖学和功能性技术。解剖学成像确定原发性病变的局部范围,为手术规划提供所需的关键信息。功能性成像不仅能确定转移性疾病的扩散范围,还能提供有关肿瘤生物学行为的重要信息,使临床医生能够决定最合适的治疗方式。我们回顾了关于该主题的当前文献,重点关注每种成像方式的优势。

相似文献

1
Imaging of gastroenteropancreatic neuroendocrine tumors.
World J Clin Oncol. 2011 Jan 10;2(1):28-43. doi: 10.5306/wjco.v2.i1.28.
2
Somatostatin-receptor imaging of neuroendocrine gastroenteropancreatic tumors.
Gastroenterology. 1993 Dec;105(6):1705-9. doi: 10.1016/0016-5085(93)91066-q.
4
Somatostatin receptor scintigraphy in the diagnosis of neuroendocrine gastroenteropancreatic tumors.
Recent Results Cancer Res. 1996;142:137-62. doi: 10.1007/978-3-642-80035-1_10.
6
Molecular imaging of gastroenteropancreatic neuroendocrine tumors.
Gastroenterol Clin North Am. 2010 Dec;39(4):923-35. doi: 10.1016/j.gtc.2010.08.031. Epub 2010 Oct 8.
7
[Contributions of nuclear medicine to the diagnosis and follow-up of gastroenteropancreatic neuroendocrine tumors].
Endocrinol Nutr. 2009 Sep;56 Suppl 3:14-9. doi: 10.1016/S1575-0922(09)73505-3.
10
Nuclear medicine techniques for the imaging and treatment of neuroendocrine tumours.
Endocr Relat Cancer. 2011 Oct 17;18 Suppl 1:S27-51. doi: 10.1530/ERC-10-0282. Print 2011 Oct.

引用本文的文献

1
Peritoneal metastases in patients with neuroendocrine neoplasms: a challenging site of metastases with clinical and prognostic implications.
J Endocrinol Invest. 2024 Sep;47(9):2295-2303. doi: 10.1007/s40618-024-02330-5. Epub 2024 Mar 7.
2
Neuroendocrine tumor of the gall bladder: A rare case report with review of literature.
Radiol Case Rep. 2023 Aug 26;18(11):3912-3916. doi: 10.1016/j.radcr.2023.08.015. eCollection 2023 Nov.
4
Correlation of four-phase CT findings of rectal neuroendocrine neoplasms with different World Health Organization grades.
Abdom Radiol (NY). 2023 Mar;48(3):855-864. doi: 10.1007/s00261-022-03771-3. Epub 2022 Dec 28.
5
Advances in the imaging of gastroenteropancreatic neuroendocrine neoplasms.
World J Gastroenterol. 2022 Jul 14;28(26):3008-3026. doi: 10.3748/wjg.v28.i26.3008.
6
The role of HMGA1 protein in gastroenteropancreatic neuroendocrine tumors.
Cell Cycle. 2022 Jun;21(12):1335-1346. doi: 10.1080/15384101.2022.2050646. Epub 2022 Mar 14.
7
Diagnostic imaging of gastrointestinal neuroendocrine neoplasms with a focus on ultrasound.
J Ultrason. 2019 Nov;19(78):228-235. doi: 10.15557/JoU.2019.0034. Epub 2019 Sep 30.
8
Molecular imaging of a glucagonoma with F-FDG PET/CT and Ga-DOTATATE PET/CT imaging: A case report and review of the literature.
Radiol Case Rep. 2019 Nov 8;15(1):19-22. doi: 10.1016/j.radcr.2019.10.007. eCollection 2020 Jan.
10
Evaluation of a Neurokinin-1 Receptor-Targeted Technetium-99m Conjugate for Neuroendocrine Cancer Imaging.
Mol Imaging Biol. 2020 Apr;22(2):377-383. doi: 10.1007/s11307-019-01391-w.

本文引用的文献

1
68Ga-DOTANOC PET/CT clinical impact in patients with neuroendocrine tumors.
J Nucl Med. 2010 May;51(5):669-73. doi: 10.2967/jnumed.109.071712. Epub 2010 Apr 15.
3
68Ga-DOTA-Tyr3-octreotide PET for assessing response to somatostatin-receptor-mediated radionuclide therapy.
J Nucl Med. 2009 Sep;50(9):1427-34. doi: 10.2967/jnumed.108.053421. Epub 2009 Aug 18.
4
Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy.
J Nucl Med. 2009 Aug;50(8):1214-21. doi: 10.2967/jnumed.108.060236. Epub 2009 Jul 17.
6
Predictive value of 18F-FDG PET and somatostatin receptor scintigraphy in patients with metastatic endocrine tumors.
J Nucl Med. 2009 Jun;50(6):858-64. doi: 10.2967/jnumed.108.057505. Epub 2009 May 14.
7
Intraindividual comparison of 68Ga-DOTA-TATE and 18F-DOPA PET in patients with well-differentiated metastatic neuroendocrine tumours.
Eur J Nucl Med Mol Imaging. 2009 May;36(5):765-70. doi: 10.1007/s00259-008-1030-8. Epub 2009 Jan 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验